Invention Grant
![Hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds](/docs/US/2017-01-24/US09550795B2/abs.jpg.600x600.jpg)
- Patent Title: Hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
- Patent Title (中): 六氢吡喃并[3,4-d] [1,3]噻嗪-2-胺化合物
-
Application No.: US14560190Application Date: 2014-12-04
-
Publication No.: US09550795B2Publication Date: 2017-01-24
- Inventor: Michael Aaron Brodney , Christopher Ryan Butler , Christopher John Helal , Brian Thomas O'Neill
- Applicant: Michael Aaron Brodney , Christopher Ryan Butler , Christopher John Helal , Brian Thomas O'Neill
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agent John A. Wichtowski
- Main IPC: C07D513/04
- IPC: C07D513/04
![Hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds](/abs-image/US/2017/01/24/US09550795B2/abs.jpg.150x150.jpg)
Abstract:
Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I, as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
Public/Granted literature
- US20150087637A1 Hexahydropyrano[3,4-d][1,3]Thiazin-2-Amine Compounds Public/Granted day:2015-03-26
Information query
